184 related articles for article (PubMed ID: 9339683)
1. A novel sodium channel mutation causing a hyperkalemic paralytic and paramyotonic syndrome with variable clinical expressivity.
Wagner S; Lerche H; Mitrovic N; Heine R; George AL; Lehmann-Horn F
Neurology; 1997 Oct; 49(4):1018-25. PubMed ID: 9339683
[TBL] [Abstract][Full Text] [Related]
2. Slow inactivation differs among mutant Na channels associated with myotonia and periodic paralysis.
Hayward LJ; Brown RH; Cannon SC
Biophys J; 1997 Mar; 72(3):1204-19. PubMed ID: 9138567
[TBL] [Abstract][Full Text] [Related]
3. Activation and inactivation of the voltage-gated sodium channel: role of segment S5 revealed by a novel hyperkalaemic periodic paralysis mutation.
Bendahhou S; Cummins TR; Tawil R; Waxman SG; Ptácek LJ
J Neurosci; 1999 Jun; 19(12):4762-71. PubMed ID: 10366610
[TBL] [Abstract][Full Text] [Related]
4. Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis.
Ptacek LJ; Gouw L; Kwieciński H; McManis P; Mendell JR; Barohn RJ; George AL; Barchi RL; Robertson M; Leppert MF
Ann Neurol; 1993 Mar; 33(3):300-7. PubMed ID: 8388676
[TBL] [Abstract][Full Text] [Related]
5. Paramyotonia congenita and hyperkalemic periodic paralysis associated with a Met 1592 Val substitution in the skeletal muscle sodium channel alpha subunit--a large kindred with a novel phenotype.
Kelly P; Yang WS; Costigan D; Farrell MA; Murphy S; Hardiman O
Neuromuscul Disord; 1997 Mar; 7(2):105-11. PubMed ID: 9131651
[TBL] [Abstract][Full Text] [Related]
6. Impairment of slow inactivation as a common mechanism for periodic paralysis in DIIS4-S5.
Bendahhou S; Cummins TR; Kula RW; Fu YH; Ptácek LJ
Neurology; 2002 Apr; 58(8):1266-72. PubMed ID: 11971097
[TBL] [Abstract][Full Text] [Related]
7. A1152D mutation of the Na+ channel causes paramyotonia congenita and emphasizes the role of DIII/S4-S5 linker in fast inactivation.
Bouhours M; Luce S; Sternberg D; Willer JC; Fontaine B; Tabti N
J Physiol; 2005 Jun; 565(Pt 2):415-27. PubMed ID: 15790667
[TBL] [Abstract][Full Text] [Related]
8. Different effects of mexiletine on two mutant sodium channels causing paramyotonia congenita and hyperkalemic periodic paralysis.
Weckbecker K; Würz A; Mohammadi B; Mansuroglu T; George AL; Lerche H; Dengler R; Lehmann-Horn F; Mitrovic N
Neuromuscul Disord; 2000 Jan; 10(1):31-9. PubMed ID: 10677861
[TBL] [Abstract][Full Text] [Related]
9. Effects of temperature and mexiletine on the F1473S Na+ channel mutation causing paramyotonia congenita.
Fleischhauer R; Mitrovic N; Deymeer F; Lehmann-Horn F; Lerche H
Pflugers Arch; 1998 Oct; 436(5):757-65. PubMed ID: 9716710
[TBL] [Abstract][Full Text] [Related]
10. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis.
Ptáĉek LJ; Tawil R; Griggs RC; Meola G; McManis P; Barohn RJ; Mendell JR; Harris C; Spitzer R; Santiago F
Neurology; 1994 Aug; 44(8):1500-3. PubMed ID: 8058156
[TBL] [Abstract][Full Text] [Related]
11. Different effects on gating of three myotonia-causing mutations in the inactivation gate of the human muscle sodium channel.
Mitrović N; George AL; Lerche H; Wagner S; Fahlke C; Lehmann-Horn F
J Physiol; 1995 Aug; 487(1):107-14. PubMed ID: 7473241
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the muscle sodium channel gene (SCN4A) in 13 French families with hyperkalemic periodic paralysis and paramyotonia congenita: phenotype to genotype correlations and demonstration of the predominance of two mutations.
Plassart E; Reboul J; Rime CS; Recan D; Millasseau P; Eymard B; Pelletier J; Thomas C; Chapon F; Desnuelle C
Eur J Hum Genet; 1994; 2(2):110-24. PubMed ID: 8044656
[TBL] [Abstract][Full Text] [Related]
13. N1366S mutation of human skeletal muscle sodium channel causes paramyotonia congenita.
Ke Q; Ye J; Tang S; Wang J; Luo B; Ji F; Zhang X; Yu Y; Cheng X; Li Y
J Physiol; 2017 Nov; 595(22):6837-6850. PubMed ID: 28940424
[TBL] [Abstract][Full Text] [Related]
14. Functional consequences of a Na+ channel mutation causing hyperkalemic periodic paralysis.
Cummins TR; Zhou J; Sigworth FJ; Ukomadu C; Stephan M; Ptácek LJ; Agnew WS
Neuron; 1993 Apr; 10(4):667-78. PubMed ID: 8386527
[TBL] [Abstract][Full Text] [Related]
15. Enhanced slow inactivation by V445M: a sodium channel mutation associated with myotonia.
Takahashi MP; Cannon SC
Biophys J; 1999 Feb; 76(2):861-8. PubMed ID: 9929487
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization and cold sensitivity of T1313A, a new mutation of the skeletal muscle sodium channel causing paramyotonia congenita in humans.
Bouhours M; Sternberg D; Davoine CS; Ferrer X; Willer JC; Fontaine B; Tabti N
J Physiol; 2004 Feb; 554(Pt 3):635-47. PubMed ID: 14617673
[TBL] [Abstract][Full Text] [Related]
17. Sodium channel mutations in paramyotonia congenita exhibit similar biophysical phenotypes in vitro.
Yang N; Ji S; Zhou M; Ptácek LJ; Barchi RL; Horn R; George AL
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12785-9. PubMed ID: 7809121
[TBL] [Abstract][Full Text] [Related]
18. A C-terminal skeletal muscle sodium channel mutation associated with myotonia disrupts fast inactivation.
Wu FF; Gordon E; Hoffman EP; Cannon SC
J Physiol; 2005 Jun; 565(Pt 2):371-80. PubMed ID: 15774523
[TBL] [Abstract][Full Text] [Related]
19. A novel SCN4A mutation causing myotonia aggravated by cold and potassium.
Heine R; Pika U; Lehmann-Horn F
Hum Mol Genet; 1993 Sep; 2(9):1349-53. PubMed ID: 8242056
[TBL] [Abstract][Full Text] [Related]
20. A novel N440K sodium channel mutation causes myotonia with exercise-induced weakness--exclusion of CLCN1 exon deletion/duplication by MLPA.
Lehmann-Horn F; Orth M; Kuhn M; Jurkat-Rott K
Acta Myol; 2011 Oct; 30(2):133-7. PubMed ID: 22106717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
